Literature DB >> 874048

Catecholamine metabolism in thyroid disease. II. Norepinephrine secretion rate in hyperthyroidism and hypothyroidism.

P Coulombe, J H Dussault, P Walker.   

Abstract

We have measured the secretion rate of norepinephrine (NE) in 6 euthyroid subjects, 6 hyperthyroid and 6 hypothyroid patients, infused at a constant rate (0.1 microC/kg/min) for 1 h with tritiated norepinephrine (New England Nuclear Inc.). Plasma NE concentrations were measured by a modification of the fluorometric method of Anton and Sayre. A significant linear relationship was observed between plasma NE and age in normal subjects. Accordingly, values for plasma NE have been corrected for age. Plasma NE concentration was 18.3 +/- 4.2 ng/100 ml (mean+/-SEM) in normal subjects compared with 17.5 +/- 3.3 ng/100 ml in hyperthyroid patients. There was a significant elevation of plasma NE (30.3 +/- 2.9 ng/100 ml) in hypothyroid patients (P less than 0.05). A significant elevation was observed in plasma NE secretion rates in hypothyroidism 4.62 +/- 0.98 microgram/kg/day (P less than 0.02) when compared to the control group (1.46 +/- 0.35 microgram/kg/day). No significant difference was observed between the hyperthyroid group (1.74 +/- 0.49 microgram/kg/day) and the controls. These data indicate that the plasma NE secretion rate is normal in hyperthyroidism, and is significantly elevated in hypothyroidism thereby explaining the higher plasma NE concentrations seen in hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 874048     DOI: 10.1210/jcem-44-6-1185

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

Review 1.  Thyroid emergencies.

Authors:  Nicholas J Sarlis; Loukas Gourgiotis
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

Review 2.  Pathophysiology of sympathoadrenal system.

Authors:  R Giorgino
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

3.  Influence of hypo- and hyperthyroidism on plasma catecholamines in pithed rats.

Authors:  M Nagel-Hiemke; G Gross; I Lues; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-09       Impact factor: 3.000

4.  Increased fat and skeletal muscle beta-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis.

Authors:  S B Liggett; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

5.  Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis in the rat.

Authors:  J H Oppenheimer; H L Schwartz; J T Lane; M P Thompson
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

6.  Decreased adrenomedullary function in infants with classical congenital adrenal hyperplasia.

Authors:  Mimi S Kim; Anna Ryabets-Lienhard; Bhavna Bali; Christianne J Lane; Ashley H Park; Sandra Hall; Mitchell E Geffner
Journal:  J Clin Endocrinol Metab       Date:  2014-05-30       Impact factor: 5.958

7.  Short-term variability of blood pressure and heart rate in hyperthyroidism.

Authors:  A Girard; F C Hugues; C Le Jeunne; J L Elghozi
Journal:  Clin Auton Res       Date:  1998-06       Impact factor: 4.435

8.  Interrelationships among thyroxine, growth hormone, and the sympathetic nervous system in the regulation of 5'-iodothyronine deiodinase in rat brown adipose tissue.

Authors:  J E Silva; P R Larsen
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

9.  Effect of thyroid status on beta-adrenoceptors and calcium channels in rat cardiac and vascular tissue.

Authors:  M H Hawthorn; P Gengo; X Y Wei; A Rutledge; J F Moran; S Gallant; D J Triggle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

10.  Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte beta-adrenergic receptor density in man.

Authors:  A M Ginsberg; W E Clutter; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.